SCHEMBL4814808

SCHEMBL4814808

CC(=O)OC(CCl)Cn1c2ccccc2c2cc(/C=N/N(c3ccccc3)c3ccccc3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
KDM4E B2RXH2 6/20 0.42
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
HPGD P15428 6/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
MAPT P10636 5/20 0.42
LMNA P02545 4/20 0.42
POLB P06746 4/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42
SRC P12931 4/20 0.41
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PLK1 P53350 1/20 0.39
RCE1 Q9Y256 1/20 0.38
GCGR P47871 1/20 0.37
PTGER4 P35408 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4814812 1.00 ALDH1A1 (0.42) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4825904 0.97 MEN1 (0.41) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4825905 0.97 MEN1 (0.41) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4814789 0.83 CRY1 (0.34) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4814796 0.83 CRY1 (0.34) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL9189270 0.80 KDM4E (0.51) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4821975 0.79 BACE1 (0.47) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4814647 0.78 PTGER4 (0.47) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL4825653 0.77 KDM4E (0.39) ALDH1A1KDM4EMEN1KMT2AHPGD
Formaldehyde SCHEMBL27608246 0.77 BACE1 (0.45) ALDH1A1KDM4EMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7445877-B2 Charge transport materials having a central disulfane linkage SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-11-04 US disclosed
US-7326506-B2 Bridged charge transport materials having a central sulfur atom linkage SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-02-05 US disclosed
EP-1600821-B1 Bridged charge transport materials having a central sulfur atom linkage SAMSUNG ELECTRONICS CO LTD (KR) 2007-02-28 EP disclosed
US-20050277038-A1 Charge transport materials having a central disulfane linkage S-PRINTING SOLUTION CO., LTD. (KR) 2005-12-15 US disclosed
US-20050266329-A1 Bridged charge transport materials having a central sulfur atom linkage S-PRINTING SOLUTION CO., LTD. (KR) 2005-12-01 US disclosed
EP-1600821-A1 Bridged charge transport materials having a central sulfur atom linkage Samsung Electronics Co., Ltd. (KR) 2005-11-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050266329-A1 Bridged charge transport materials having a central sulfur atom linkage NR2E3, NR4A2, NR2C2 ALDH1A1 1796/4885KDM4E 3516/4885MEN1 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.